Filter
3630
Filtered Results: 3630
Text search:
HIV-positive
patients
Featured
Recommendations
335
New Publications
1020
Language
Document type
No document type
2437
Studies & Reports
454
Guidelines
404
Manuals
143
Strategic & Response Plan
70
Training Material
45
Fact sheets
43
Situation Updates
20
Infographics
8
Resource Platforms
3
Brochures
2
Online Courses
1
Countries / Regions
India
186
South Africa
144
Kenya
124
Tanzania
88
Malawi
85
Uganda
80
Ethiopia
78
Global
75
Western and Central Europe
75
Zambia
72
Nigeria
68
Liberia
65
Sierra Leone
59
Nepal
55
Rwanda
54
Africa
50
Myanmar / Burma
48
Namibia
47
Eastern Europe
42
Lesotho
37
Ukraine
36
Ghana
36
Latin America and the Carribbean
35
Bangladesh
34
Zimbabwe
29
Cambodia
29
Senegal
28
Asia
28
Germany
25
Congo, Democratic Republic of
25
Mozambique
23
Botswana
23
Philippines
22
South–East Asia Region
19
Burkina Faso
17
Russia
16
Haiti
15
Benin
14
Cameroon
14
Indonesia
14
Guinea
13
Albania
12
East and Southern Africa
11
Brazil
11
Eswatini/ Swaziland
11
Argentina
10
South Sudan
10
Venezuela
9
Madagascar
9
Colombia
8
Eastern Europe and Central Asia
8
Georgia
8
Central African Republic
8
Tajikistan
7
Syria
7
West and Central Africa
7
Middle East and North Africa
7
Southern Africa
7
Vietnam
7
Pakistan
7
Thailand
5
Ecuador
5
North Macedonia
4
Peru
4
USA
4
Somalia
4
El Salvador
3
Turkey
3
Iran
3
Estonia
3
Armenia
3
Jordan
3
Western Pacific Region
3
Lebanon
3
Sri Lanka
3
Switzerland
2
Timor Leste/ East Timor
2
Gambia
2
Chile
2
Laos
2
Niger
2
Afghanistan
2
Burundi
2
Paraguay
2
United Kingdom
2
Bolivia
2
Papua New Guinea
2
Moldova
2
Sudan
2
Yemen
2
Romania
2
Poland
2
Angola
2
Bhutan
2
Iraq
2
North Korea
1
Mexico
1
Serbia
1
China
1
Kazakhstan
1
Canada
1
Singapore
1
Uzbekistan
1
Morocco
1
Bulgaria
1
Hungary
1
Saudi Arabia
1
Gabon
1
Turkmenistan
1
France
1
Mauritius
1
Tunisia
1
Portugal
1
Spain
1
Israel
1
Côte d’Ivoire / Ivory Coast
1
Greece
1
Honduras
1
Mali
1
Chad
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
1515
Clinical Guidelines
342
Women & Child Health
173
Public Health
136
Capacity Building
78
Key Resources
71
Pharmacy & Technologies
45
Annual Report MEDBOX
1
Toolboxes
HIV
604
TB
518
COVID-19
175
Mental Health
147
AMR
102
Caregiver
99
Ebola
73
NTDs
70
Refugee
62
Rapid Response
53
Pharmacy
42
Disability
40
Global Health Education
39
Conflict
31
NCDs
29
Planetary Health
18
Health Financing Toolbox
17
Polio
17
Cholera
13
Zika
13
Natural Hazards
10
Social Ethics
7
I examine the effectiveness of donors in targeting the highest burden of malaria in the Democratic Republic of Congo when health information structure is fragmented. I exploit local variations in the burden of malaria induced by mining activities as well as financial and epidemiological data from he...
The key actions, activities, and approaches in this document are organized within each of the 5Cs (see Table 1 in the PDF) and those of the Strategic preparedness and response plan (SPRP) pillars as follows:
National action plan key activities, prioritized for the current context and the current ...
In an ambitious new era for health development under the 2030 Agenda for Sustainable Development, WHO and
its partners have a solid foundation of success on which to build. Health plays a fundamental role in development
and is the central focus of Sustainable Development Goal 3, “Ensure healthy ...
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
Laboratory manual for yellow fever
recommended
This WHO laboratory manual provides the most up to date methods and procedures for the laboratory identification of yellow fever virus infection in humans. It provides guidance on the establishment and maintenance of an effective laboratory providing routine surveillance testing for yellow fever, wh...
As the Americas undergo profound demographic change and there are more persons aged 65 years or older than children younger than 5 years, it is crucial to recognize that national immunization programs must be redesigned to ensure comprehensive protection for individuals across the lifespan. By adopt...
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expa...
Diabetes mellitus, commonly known as diabetes, is a group of metabolic disorders characterized by the presence of hyperglycaemia in the absence of treatment. The heterogeneous aetiopathology includes defects in insulin secretion, insulin action, or both. The long-term specific complications of diabe...
People with disabilities experience significant health inequalities. In Malawi, where most individuals live in low-income rural settings, many of these inequalities are exacerbated by restricted access to health care services. This qualitative study explores the barriers to health care access experi...
Mpox continues to affect people around the world. A new framework released today by WHO will guide health authorities, communities and other stakeholders in preventing and controlling mpox outbreaks, eliminating human-to-human transmission of the disease, and reducing spillover of the virus from ani...
WHO’s Country Cooperation Strategy (CCS) defines the Organization’s medium-term vision for working in and with a particular country. The CCS, developed in the context of global and national health priorities, examines the overall health situation in a country, including the state of the health s...
Key stakeholders must be involved in the planning, implementation, monitoring and evaluation of NCD plans and programmes. Within a ministry of health there will be different types of stakeholders, such as programme managers and senior managers in departments of prevention, health promotion, and hosp...
Bonchial asthma is the most common chronic respiratory disease in the world. In Kenya, it has been estimated that about 7.5% of the Kenyan population, nearly 4 million people, are currently living with asthma. Many cases tend to be underdiagnosed and undertreated which leads to high levels of morbid...
The guidance document provides a set of indicators for assessing the status of development, implementation and monitoring of key policy interventions for prevention and control of NCDs and injuries. It promotes city-level evidence based decision-making processes to identify gaps and take appropriate...
On August 13, 2024, the Africa CDC declared the mpox outbreak a Public Health Emergency of Continental Security (PHECS). The following day, the WHO declared it a Public Health Emergency of International Concern (PHEIC). A coordinated, continent-wide response is essential, co-led by the African Union...
Toolkit regarding Zika Virus
This integrated operational framework provides an overview of the connections between mental health, neurological and substance use (MNS) conditions, and their links to health, well-being and the broader public health and sustainable development agenda. The need for integrated approaches is increasi...
Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...
Antimicrobials are medicines, including antibiotics, antivirals, antifungals, and antiparasitics, that are used to prevent and treat infections in humans, animals, and plants. Antimicrobial Resistance (AMR) arises when bacteria, viruses, fungi, and parasites no longer respond to these medicines, ren...
Effective malaria case management requires quick access to diagnostics and antimalarial treatments to reduce illness and death. Artemisinin-based combination therapy (ACT) has been essential to malaria treatment since 2001, as it combines artemisinin for rapid parasite reduction with a partner drug ...
